Mayfair Gold wins Ontario fast-track permitting status for Fenn-Gib as C$310m financing plans advance
Read More Pharma Industry News Gilead Sciences acquisition of MYR: A strategic move to tackle hepatitis delta virus In a strategic acquisition aimed at expanding its hepatitis treatment portfolio, US biopharmaceutical giant Gilead Sciences has announced… bypharmanewsdailyDecember 12, 2020